CBI Arrests CBN Inspector, Middleman For Taking Rs 3 Lakh Bribe In Rajasthan

Chittorgarh:  The Central Bureau of Investigation (CBI) has arrested an inspector of the Central Narcotics Bureau (CBN) of Chittorgarh and a middleman while taking bribe. A bribe of Rs 20 lakh was demanded to settle a case against a clinic. The accused inspector has been caught taking a bribe of Rs 3 lakh through a middleman. At present, the CBI team is busy interrogating both the accused.(Video)

The complainant filed a complaint with the Central Bureau of Investigation (CBI). In this, the inspector of the Central Narcotics Bureau (CBN) of Chittorgarh is demanding a bribe of Rs 3 lakh through a middleman. The bribe amount is being demanded by the accused to settle the case against his clinic. A bribe of Rs 20 lakh was demanded to settle the case. After that, a bribe of Rs 8 lakh was demanded by the accused.

On the complaint, a case was registered on Wednesday against the accused Inspector Adarsh ​​Yogi of the Central Narcotics Bureau and middleman Keshav. Then the CBI laid a trap and caught the middleman Keshav red-handed while taking a bribe of Rs 3 lakh from Chittorgarh NCB Inspector Adarsh ​​Yogi. During the search, the team also found many objectionable documents, which were seized by the CBI. At present, the CBI team is busy interrogating both the accused.

Related Posts

  • Pharma
  • December 24, 2024
  • 15 views
FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

The FDA today approved the first generic referencing the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide (Victoza), an 18 mg/3 mL injection, to improve glycemic control in patients aged 10 years and older…

  • Pharma
  • December 24, 2024
  • 73 views
Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug

Aurobindo Pharma shares jumped 2% to an intraday high of Rs 1,265 on the BSE after its wholly owned step-down subsidiary CuraTeQ Biologics received approval from the UK‘s Medicines and Healthcare products Regulatory Agency…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes

HC denies bail to pharma company owner for manufacturing spurious drugs

HC denies bail to pharma company owner for manufacturing spurious drugs

Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug

Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug

Ho-Lis-Tic, are ‘bols’ of Cure Tabla Maestro Zakir Hussain missed

Ho-Lis-Tic, are ‘bols’ of Cure Tabla Maestro Zakir Hussain missed

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations